Page last updated: 2024-08-25

bendamustine hydrochloride and Weight Reduction

bendamustine hydrochloride has been researched along with Weight Reduction in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Gurung, R; Robertson, C; Vickers, MA	1
Cordes, SF; Liang, JJ; Witzig, TE	1
Allendorf, DJ; Bordoni, RE; Dixon, PM; Grant, SC; Jerome, ML; Miley, DK; Reddy, VB; Robert, F; Saleh, MN; Singh, KP	1

Trials

1 trial(s) available for bendamustine hydrochloride and Weight Reduction

Article	Year
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC). Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Brain Diseases, Metabolic; Camptothecin; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Endonucleases; Etoposide; Fatigue; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitosis; Multiple Organ Failure; Pneumonia; Treatment Outcome; Weight Loss	2015

Article

Year

Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).

Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Brain Diseases, Metabolic; Camptothecin; Carboplatin; Carcinoma, Small Cell; Disease-Free Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Endonucleases; Etoposide; Fatigue; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Irinotecan; Kaplan-Meier Estimate; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitosis; Multiple Organ Failure; Pneumonia; Treatment Outcome; Weight Loss

2015

Other Studies

2 other study(ies) available for bendamustine hydrochloride and Weight Reduction

Article	Year
Paraprotein associated syndrome treated successfully with chemotherapy. BMJ case reports, 2020, Sep-09, Volume: 13, Issue:9 Topics: Abdominal Pain; Antineoplastic Agents; Bendamustine Hydrochloride; Diagnosis, Differential; Erythema Nodosum; Female; Humans; Immunoglobulin M; Lymphocytosis; Middle Aged; Paraproteins; Patient Care Management; Rituximab; Schnitzler Syndrome; Treatment Outcome; Weight Loss	2020
More than skin-deep. Cleveland Clinic journal of medicine, 2013, Volume: 80, Issue:10 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Dexamethasone; Humans; Lymphoma, Non-Hodgkin; Male; Nail Diseases; Nitrogen Mustard Compounds; Oral Ulcer; Paraneoplastic Syndromes; Pemphigus; Rituximab; Weight Loss	2013

Article

Year

Paraprotein associated syndrome treated successfully with chemotherapy.

BMJ case reports, 2020, Sep-09, Volume: 13, Issue:9

Topics: Abdominal Pain; Antineoplastic Agents; Bendamustine Hydrochloride; Diagnosis, Differential; Erythema Nodosum; Female; Humans; Immunoglobulin M; Lymphocytosis; Middle Aged; Paraproteins; Patient Care Management; Rituximab; Schnitzler Syndrome; Treatment Outcome; Weight Loss

2020

More than skin-deep.

Cleveland Clinic journal of medicine, 2013, Volume: 80, Issue:10

Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Dexamethasone; Humans; Lymphoma, Non-Hodgkin; Male; Nail Diseases; Nitrogen Mustard Compounds; Oral Ulcer; Paraneoplastic Syndromes; Pemphigus; Rituximab; Weight Loss

2013